Di LJ - Search Results

1

[Randomized phase II trial on escalated doses of Rh-endostatin (YH-16) for advanced non-small cell lung cancer].

Yang L, Wang JW, Sun Y, Zhu YZ, Liu XQ, Li WL, Di LJ, Li PW, Wang YL, Song SP, Yao C, You LF. Yang L, et al. Among authors: di lj. Zhonghua Zhong Liu Za Zhi. 2006 Feb;28(2):138-41. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 16750022 Clinical Trial. Chinese.

2

[Cancer pain and its influence on cancer patients' quality of life].

Nie J, Liu S, Di L. Nie J, et al. Zhonghua Zhong Liu Za Zhi. 2000 Sep;22(5):432-4. Zhonghua Zhong Liu Za Zhi. 2000. PMID: 11778286 Chinese.

3

[Amifostin in protection of kidney from cisplatinum injury].

Cui H, Zhang S, Li P, Guan Z, Sun X, Shen K, Wu M, Hu X, Liu S, Di L, Zhang S. Cui H, et al. Zhonghua Zhong Liu Za Zhi. 2002 Jan;24(1):48-50. Zhonghua Zhong Liu Za Zhi. 2002. PMID: 11977638 Clinical Trial. Chinese.

4

[Phase II clinical trial on gemcitabine in the treatment of stage IIIB-IV non-small cell lung cancer].

Liu SJ, Di LJ, Wang J, Li R, Yang L, Sun H, Zhang MH, Li L, Liu JW, Gao YJ, Sun H, Xu GW. Liu SJ, et al. Among authors: di lj. Zhonghua Zhong Liu Za Zhi. 2003 Nov;25(6):584-6. Zhonghua Zhong Liu Za Zhi. 2003. PMID: 14690568 Clinical Trial. Chinese.

5

[Efficacy of gemcitabine-based chemotherapy on advanced pancreatic cancer].

Gong JF, Zhang XD, Li J, Di LJ, Jin ML, Shen L. Gong JF, et al. Among authors: di lj. Ai Zheng. 2007 Aug;26(8):890-4. Ai Zheng. 2007. PMID: 17697554 Free article. Chinese.

6

[Randomized clinical case-control trial for the comparison of docetaxel plus thiotepa versus docetaxel plus capecitabine in patients with metastatic breast cancer].

Yu J, DI Lj, Song Gh, Che L, Jiang Hf, Zhu Yl, Liang X, Jia J, Zhang J, Yang Hb, Wang Xl, Zhou Xn, Ren J. Yu J, et al. Among authors: di lj. Beijing Da Xue Xue Bao Yi Xue Ban. 2011 Feb 18;43(1):151-6. Beijing Da Xue Xue Bao Yi Xue Ban. 2011. PMID: 21321641 Free article. Clinical Trial. Chinese.

7

[Concurrent versus sequential systemic chemotherapy and whole brain radiation therapy for brain matastases in non-small-cell lung cancer patients].

Jiang HF, Fang J, Ren J, DI LJ, Song GH, Che L, Yu J, Zhu YL. Jiang HF, et al. Among authors: di lj. Zhonghua Zhong Liu Za Zhi. 2011 Jan;33(1):58-62. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 21575467 Clinical Trial. Chinese.

8

Recombinant human endostatin could eliminate the pro-angiogenesis priority of SP cells sorted from non-small cell lung cancer cells.

Cao B, Jia J, Ma L, Di L, Song G, Yuan Y, Ma B, Zhu Y, Yu J, Wang X, Zhou X, Lyerly HK, Ren J. Cao B, et al. Clin Transl Oncol. 2012 Aug;14(8):575-85. doi: 10.1007/s12094-012-0844-9. Epub 2012 Jul 21. Clin Transl Oncol. 2012. PMID: 22855139

9

Phase II trial of utidelone as monotherapy or in combination with capecitabine in heavily pretreated metastatic breast cancer patients.

Zhang P, Tong Z, Tian F, Wang Y, Yang J, Li W, Di L, Liu W, Tang L, Qiu R, Xu B. Zhang P, et al. J Hematol Oncol. 2016 Aug 11;9(1):68. doi: 10.1186/s13045-016-0297-7. J Hematol Oncol. 2016. PMID: 27516093 Free PMC article. Clinical Trial.

10

[Phase Ⅲ randomized controlled, multicenter, prospective study of recombinant anti-HER2 humanized monoclonal antibody (Cipterbin) combined with vinorelbine in patients with HER2 positive metastatic breast cancer: the HOPES Study].

Bian L, Xu BH, Di LJ, Wang T, Wang XJ, Jiao SC, Yang JL, Tong ZS, Liu J, Feng JF, Liu DG, Yu QT, Liu YP, Ma Y, Yu H, Jiang ZF. Bian L, et al. Among authors: di lj. Zhonghua Yi Xue Za Zhi. 2020 Aug 11;100(30):2351-2357. doi: 10.3760/cma.j.cn112137-20200116-00105. Zhonghua Yi Xue Za Zhi. 2020. PMID: 32791810 Clinical Trial. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

119 results

Search Page